211 related articles for article (PubMed ID: 15182776)
1. Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
Willenheimer R; Erdmann E; Follath F; Krum H; Ponikowski P; Silke B; Van Veldhuisen DJ; Van De Ven L; Verkenne P; Lechat P;
Eur J Heart Fail; 2004 Jun; 6(4):493-500. PubMed ID: 15182776
[TBL] [Abstract][Full Text] [Related]
2. Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
Funck-Brentano C; van Veldhuisen DJ; van de Ven LL; Follath F; Goulder M; Willenheimer R;
Eur J Heart Fail; 2011 Jul; 13(7):765-72. PubMed ID: 21551161
[TBL] [Abstract][Full Text] [Related]
3. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
[TBL] [Abstract][Full Text] [Related]
4. Using Cardicor as first-line therapy in heart failure : CiBis iii.
Cardiovasc J Afr; 2009; 20(1):78. PubMed ID: 19382368
[No Abstract] [Full Text] [Related]
5. [Chronic heart failure and sudden death: the message of CIBIS-III].
Dequarti MC; Poggio L; Vanoli E
Recenti Prog Med; 2007 Dec; 98(12):638-45. PubMed ID: 18369041
[TBL] [Abstract][Full Text] [Related]
6. Implications of CIBIS III: a commentary.
Willenheimer R
J Renin Angiotensin Aldosterone Syst; 2005 Dec; 6(3):115-20. PubMed ID: 16525941
[TBL] [Abstract][Full Text] [Related]
7. Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment.
Andersson B; Kjörk E; Brunlöf G
Int J Cardiol; 2005 Oct; 104(3):257-63. PubMed ID: 16186053
[TBL] [Abstract][Full Text] [Related]
8. The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
van de Ven LL; van Veldhuisen DJ; Goulder M; Zilahi Z; Meyer WR; Willenheimer R
Int J Cardiol; 2010 Sep; 144(1):59-63. PubMed ID: 19481278
[TBL] [Abstract][Full Text] [Related]
9. [Risk reduction of acute heart failure with initial administration of beta-blockers].
Med Monatsschr Pharm; 2007 Apr; 30(4):158. PubMed ID: 17484449
[No Abstract] [Full Text] [Related]
10. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
[No Abstract] [Full Text] [Related]
11. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
Gosse P; Roudaut R; Herrero G; Dallocchio M
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
[TBL] [Abstract][Full Text] [Related]
12. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
[TBL] [Abstract][Full Text] [Related]
13. Effect on mode of death of heart failure treatment started with bisoprolol followed by Enalapril, compared to the opposite order: results of the randomized CIBIS III trial.
Krum H; van Veldhuisen DJ; Funck-Brentano C; Vanoli E; Silke B; Erdmann E; Follath F; Ponikowski P; Goulder M; Meyer W; Lechat P; Willenheimer R;
Cardiovasc Ther; 2011 Apr; 29(2):89-98. PubMed ID: 20528880
[TBL] [Abstract][Full Text] [Related]
14. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
[TBL] [Abstract][Full Text] [Related]
15. [Acetylsalicylic acid antagonism vs ACE inhibitor in congestive heart failure as shown by a diminished respiratory and exercise capacity].
Guazzi M; Lauri G; Melzi G; Cattadori G; Agostoni P
Cardiologia; 1996 Jun; 41(6):527-33. PubMed ID: 8766415
[TBL] [Abstract][Full Text] [Related]
16. Challenging the dogma of high target doses in the treatment of heart failure: is more always better?
Follath F
Arch Cardiovasc Dis; 2009 Nov; 102(11):785-9. PubMed ID: 19944395
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.
Störk S; Hense HW; Zentgraf C; Uebelacker I; Jahns R; Ertl G; Angermann CE
Eur J Heart Fail; 2008 Dec; 10(12):1236-45. PubMed ID: 18996739
[TBL] [Abstract][Full Text] [Related]
18. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
Prichard BN; Saul PA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
[TBL] [Abstract][Full Text] [Related]
19. Bisoprolol in the treatment of chronic heart failure.
de Groote P; Ennezat PV; Mouquet F
Vasc Health Risk Manag; 2007; 3(4):431-9. PubMed ID: 17969374
[TBL] [Abstract][Full Text] [Related]
20. CIBIS III trial: Bisoprolol treatment for CHF leads to 46% reduction in sudden death after one year.
Cardiovasc J S Afr; 2006; 17(5):278. PubMed ID: 17117242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
